Helena R. Chang
Thermo Fisher Scientific (United States)(US)Thermo Fisher Scientific (Israel)(IL)
Publications by Year
Research Areas
CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR(2014)601 cited
- → Younger women with breast carcinoma have a poorer prognosis than older women(1996)377 cited
- → Cryoablation of Early-Stage Breast Cancer: Work-in-Progress Report of a Multi-Institutional Trial(2004)202 cited
- → Higher levels of GATA3 predict better survival in women with breast cancer(2010)187 cited
- → Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis(2006)114 cited
- → The prognostic value of histologic subtypes in primary extremity liposarcoma(1989)113 cited